Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.31623 | uM | 8 | 312.50 | 129.17 | 333.00 | 204.75 | 1.6264 | 3.1575 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 312.50 | 129.17 | 306.00 | 204.75 | 1.4945 | 2.6608 |
| BT-20 | 17-AAG | 0.01 | uM | 8 | 312.50 | 129.17 | 154.00 | 204.75 | 0.7521 | 0.3029 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 312.50 | 129.17 | 235.00 | 204.75 | 1.1477 | 1.4608 |
| BT-20 | Lapatinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 186.00 | 204.75 | 0.9084 | 0.7309 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 312.50 | 129.17 | 125.00 | 204.75 | 0.6105 | -0.0481 |
| BT-20 | Linsitinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 243.00 | 204.75 | 1.1868 | 1.5879 |
| BT-20 | Linsitinib | 3.1623 | uM | 8 | 312.50 | 129.17 | 212.00 | 204.75 | 1.0354 | 1.1075 |
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 312.50 | 129.17 | 245.00 | 204.75 | 1.1966 | 1.6200 |
| BT-20 | Lapatinib | 1 | uM | 8 | 312.50 | 129.17 | 192.00 | 204.75 | 0.9377 | 0.8156 |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 203.00 | 204.75 | 0.9915 | 0.9743 | |
| BT-20 | 0 | uM | 8 | 312.50 | 129.17 | 129.00 | 204.75 | 0.6300 | -0.0019 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 421.00 | 597.75 | 0.7043 | 0.4714 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 657.00 | 597.75 | 1.0991 | 1.1725 | |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 625.00 | 270.83 | 589.00 | 597.75 | 0.9854 | 0.9743 |
| BT-20 | Lapatinib | 3.1623 | uM | 8 | 625.00 | 270.83 | 435.00 | 597.75 | 0.7277 | 0.5142 |
| BT-20 | Linsitinib | 10 | uM | 8 | 625.00 | 270.83 | 549.00 | 597.75 | 0.9184 | 0.8564 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 625.00 | 270.83 | 847.00 | 597.75 | 1.4170 | 1.7137 |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 519.00 | 597.75 | 0.8683 | 0.7673 |
| BT-20 | Erlotinib | 1 | uM | 8 | 625.00 | 270.83 | 752.00 | 597.75 | 1.2581 | 1.4452 |
| BT-20 | 17-AAG | 0.0031623 | uM | 8 | 625.00 | 270.83 | 619.00 | 597.75 | 1.0355 | 1.0621 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 846.00 | 597.75 | 1.4153 | 1.7109 | |
| BT-20 | Linsitinib | 1 | uM | 8 | 625.00 | 270.83 | 878.00 | 597.75 | 1.4688 | 1.8004 |
| BT-20 | Erlotinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 843.00 | 597.75 | 1.4103 | 1.7024 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 722.00 | 597.75 | 1.2079 | 1.3596 |